Issue 5, 2024

Research advances and applications of ZIF-90 metal–organic framework nanoparticles in the biomedical field

Abstract

In recent years, metal–organic frameworks (MOFs) have been widely used in the field of pharmaceuticals, and their stable structure and chemical properties have shown great potential in applications requiring drug delivery carriers. ZIF-90, as a new type of MOF, has gradually attracted more attention in the field of biological medicine. ZIF-90 has the advantages of a large specific surface area, a uniform pore structure, and good biocompatibility. Importantly, the specific pH/ATP sensitivity and mitochondrial targeting provide an opportunity for it to become an intelligent drug delivery system. But unfortunately, there are few specialized reviews with a focus on ZIF-90. This article not only summarizes the structure, characterization, synthesis and biosecurity of ZIF-90, but also discusses the research progress using it as a therapeutic platform in anticancer therapy, biomedical imaging and other therapies for different diseases, over the past five years. In addition, the remaining challenges and future opportunities have also been evaluated. It is hoped that this review can provide a foundation for broadening the application of ZIF-90 in the clinical treatment, prevention and diagnosis of diseases.

Graphical abstract: Research advances and applications of ZIF-90 metal–organic framework nanoparticles in the biomedical field

Article information

Article type
Review Article
Submitted
18 sen 2023
Accepted
23 okt 2023
First published
27 okt 2023

Mater. Chem. Front., 2024,8, 1195-1211

Research advances and applications of ZIF-90 metal–organic framework nanoparticles in the biomedical field

S. Chen, H. Pang, J. Sun and K. Li, Mater. Chem. Front., 2024, 8, 1195 DOI: 10.1039/D3QM01020A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements